Drug pricing debates are reshaping Europe's life sciences landscape, and its relationships to global partners. FP Analytics' synthesis report, supported by @AstraZeneca, examines what it will take to restore Europe's edge in pharmaceutical innovation:

Drug pricing debates are reshaping Europe's life sciences landscape, and its relationships to global partners. FP Analytics' synthesis report, supported by @AstraZeneca, examines what it will take to restore Europe's edge in pharmaceutical innovation:

Go to News Site